title: Granulomatous liver disease.
abstract: Hepatic granulomata are not infrequently encountered in liver biopsy and often are associated with systemic disease. The clinical presentation varies with the particular systemic process. From a biochemical standpoint, the most common abnormalities are elevated serum alkaline phosphatase and γ-glutamyltransferase. The observation of granulomata in a liver biopsy specimen warrants workup to identify a possible cause. Clues may be obtained in the medical history, on physical examination, or with specialized blood testing or radiologic studies. Treatment involves therapy of the underlying cause of the disease associated with the development of the granulomatous hepatitis.
authors.affiliation: Division of Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. s-flamm@northwestern.edu
authors.forename: Steven L
authors.initials: SL
authors.lastname: Flamm
mesh_terms: D001327:Autoimmune Diseases / Q000150:complications; D064420:Drug-Related Side Effects and Adverse Reactions; D005547:Foreign Bodies / Q000150:complications; D006099:Granuloma / Q000209:etiology* / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007239:Infections / Q000150:complications* / Q000382:microbiology / Q000469:parasitology; D008105:Liver Cirrhosis, Biliary / Q000150:complications; D008107:Liver Diseases / Q000473:pathology*; D012507:Sarcoidosis / Q000150:complications*